Median of serum FABP4 levels in patients with stroke recurrence was 22.6 (IQR, 17.9-31.6) ng/mL, which was higher than those of without stroke recurrence [16.9, (IQR, 11.8-21.4) ng/mL] (Figure 2). This evidence concerns the gene FABP4 and stroke disorder.